Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Alpha-1 antitrypsin deficiency

Recruiting

Registered drug

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Fazirsiran

Contact Research Centre

Alcoholic liver disease

Recruiting

Investigational

Study on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Recruiting

Investigational

Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Namodenoson

Contact Research Centre

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Not yet recruiting

Investigational

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Type 2 diabetes mellitus+2

Not yet recruiting

Investigational

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Autoimmune hepatitis

Not yet recruiting

Registered drug

A Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Inebilizumab

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Lanifibranor

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Cagrilintide

Contact Research Centre

Bladder cancer

Not recruiting

InvestigationalNo placebo

Study of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Sasanlimab

Contact Research Centre

Alcoholic liver disease

Not recruiting

Investigational

A study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Cagrilintide

Contact Research Centre

Metabolic dysfunction-associated liver disease+2

Not recruiting

Registered drug

Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

Registered drug

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 2

41 trials match your criteria

Alpha-1 antitrypsin deficiency

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

Alcoholic liver disease

Study on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease

Metabolic dysfunction-associated steatohepatitis+1

Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Type 2 diabetes mellitus+2

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Autoimmune hepatitis

A Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Bladder cancer

Study of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG

Alcoholic liver disease

A study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease

Metabolic dysfunction-associated liver disease+2

Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.